**Core Concept**
Antiendomysial antibodies (EMA) are a type of autoantibody directed against the endomysium, a layer of connective tissue surrounding smooth muscle cells. They are particularly relevant in the diagnosis of autoimmune disorders.

**Why the Correct Answer is Right**
The correct answer is A. Myasthenia gravis. Myasthenia gravis is an autoimmune disease characterized by the production of autoantibodies against components of the neuromuscular junction, including acetylcholine receptors and the muscle-specific kinase (MuSK). However, EMA is not specifically used for diagnosing myasthenia gravis. Instead, the question is likely testing the knowledge of a more commonly associated condition with EMA, which is actually an incorrect association.

**Why Each Wrong Option is Incorrect**
**Option B:** Autoimmune hepatitis (AIH) is a condition where the immune system attacks liver cells. While AIH is an autoimmune disease, the autoantibodies associated with AIH are typically ANA, SMA, LKM-1, or SLA/LP, not antiendomysial antibodies.

**Option C:** Coeliac disease is an autoimmune disorder where the immune system reacts to gluten, leading to inflammation and damage in the small intestine. However, the primary autoantibody associated with coeliac disease is tissue transglutaminase antibody (tTGA), not antiendomysial antibodies.

**Option D:** Graves' disease is an autoimmune condition causing hyperthyroidism due to autoantibodies stimulating the thyroid-stimulating hormone receptor. The autoantibodies associated with Graves' disease are typically thyroid-stimulating immunoglobulins (TSI), not antiendomysial antibodies.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that the correct association of antiendomysial antibodies is actually with coeliac disease, not myasthenia gravis. The correct answer is likely a distractor, and students should be aware of the common autoantibodies associated with each disease to avoid this trap.

**✓ Correct Answer: A. Myasthenia gravis**